The effects of doxorubicin and radiation on apoptosis, p53 expression, and
tumor growth in human tumor xenografts were investigated. Human ependymobla
stoma (NNE), primitive neuroectodermal tumor (YKP), glioblastoma (KYG) and
small cell lung carcinoma (GLS) that are all transplantable to nude mice we
re treated with doxorubicin (8 mg/kg) or radiation (1 Gy). The histological
study was performed by using TUNEL and p53 staining. Cytotoxic effects of
doxorubicin and radiation were compared with no-treatment group by the grow
th curves and apoptotic index of tumor to each treatment. In NNE with wild-
type p53, doxorubicin induced growth delay of tumors (tumor volume doubling
time; 13.7+/-3.3 days in control group vs 30.4+/-1.5 days in doxorubicin g
roup), but no growth delay of rumors in KYG and GLS with mutant type p53. W
hile radiation-induced apoptosis appeared most frequently at 6 h after irra
diation, doxorubicin-induced apoptosis had a tendency to appear later. Furt
hermore, although the frequency of doxorubicin-induced apoptosis was lower
than that of apoptosis by 1 Gy irradiation, apoptotic cells appeared for ma
ny hours after the treatment. Doxorubicin-induced apoptosis may be correlat
ed with p53 phenotype because apoptosis was induced only in tumor with wild
-type p53, but it appeared less frequently and later than radiation-induced
apoptosis.